Safety and Performance of the Multi-Modal UltraSound Tomography (MUST) Device in Breast Cancer Screening

Recruiting in Palo Alto (17 mi)

Overseen by Tejas Mehta, MD

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Transonic Imaging, Inc.

No Placebo Group

Trial Summary

What is the purpose of this trial?

This is a single-center, pilot study being conducted to evaluate the safety and performance of the investigational device (MUST) in detecting malignant lesions in breast tissue.

Research Team

Tejas Mehta, MD

Principal Investigator

Beth Israel Deaconess Hospital

Eligibility Criteria

Inclusion Criteria

Female subject scheduled for routine screening mammogram

Not currently pregnant or breastfeeding

Age 40 to 74 years, inclusive

Treatment Details

Interventions

• MUST device (Device)

Participant Groups

Group I: Single Arm Experimental Treatment 1 Intervention

All enrolled subjects will undergo breast cancer screening with mammography and the MUST device

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Beth Israel Deaconess Medical Center BreastCare Center Boston, MA

Who Is Running the Clinical Trial?

Transonic Imaging, Inc.

Lead Sponsor

Trials

1

Patients Recruited

1,300+